Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Njord Group ApS
APS
Dissolved
Advertising protection
CVR 40737529
Sortebrovej 12, 5690
Tommerup
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Njord Group ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
Income statement
DKK thousands
Item
2020
Gross profit
50
Staff expenses
-0
EBITDA
50
Depreciation & amort.
-4
EBIT
46
Net financials
-0
Profit before tax
46
Tax
10
Net profit
36
Balance sheet
DKK thousands
Item
2020
Total assets
108
Equity
76
Long-term debt
0
Short-term debt
32
Total debt
32
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2020
2020
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
2020
2020
Return on equity
47.4%
This company
18.4%
Market median
+158% vs market
2020
2020
Net profit margin (of gross profit)
71.7%
This company
2020
2020
Asset turnover (of gross profit)
0.47×
This company
2020
2020
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
2020
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2019-08-26 – 2020-12-31
View
PDF
More on Njord Group ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
